Tristel (R1V) Price & Analysis

1 Followers

R1V Stock Chart & Stats

€4.82

€0.10(2.12%)

At close: Jul 29 4:00 PM EDT

€4.82

€0.10(2.12%)

Day’s Range― - ―

52-Week Range€3.94 - €5.50

Previous CloseN/A

Volume0.00

Average Volume (3M)73.00

Market Cap

€228.63M

Enterprise Value€181.84M

Total Cash (Recent Filing)€16.00M

Total Debt (Recent Filing)€5.86M

Price to Earnings (P/E)23.4

Beta0.19

Next Earnings

Feb 22, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.17

Shares Outstanding48,073,494

10 Day Avg. Volume19

30 Day Avg. Volume73

Financial Highlights & Ratios

PEG Ratio1.10

Price to Book (P/B)5.36

Price to Sales (P/S)3.74

P/FCF Ratio17.69

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€4.99

Price Target Upside3.43% Upside

Rating ConsensusHold

Number of Analyst Covering1

EPS Forecast (FY)0.24

Revenue Forecast (FY)€67.14M

Bulls Say, Bears Say

Bulls Say

Proprietary Technology And Defensible Market PositionA proprietary technology position supported by patents, applications and difficult-to-replicate know-how can protect product differentiation over several years. This strengthens Tristel’s ability to win regulated healthcare accounts, support premium margins and build adoption as clinical evidence and guidelines expand.

Sustained Growth With Expanding MarginsRecord revenue, double-digit growth and a 31% adjusted EBITDA margin indicate that demand is scaling without eroding profitability. The combination supports reinvestment in commercial expansion, clinical evidence and product development while reinforcing management’s long-term growth model.

Strong Cash Generation And Debt-free Balance SheetStrong operating cash flow and a debt-free position give Tristel financial flexibility to fund sales expansion, research, launches and potential partnerships internally. The cash balance also reduces balance-sheet pressure, allowing management to pursue growth while continuing progressive dividends.

Bears Say

Legacy Product Declines And Regional CompetitionDeclining legacy products and competitive or tender-related pressure can offset growth from newer offerings, particularly in mature markets. If these headwinds persist, they could make consolidated growth less predictable and require greater commercial investment to defend existing positions.

Higher Impairments And Cost BurdenHigher depreciation, amortization and impairment charges reduce reported earnings and may signal that some investments are producing less value than originally expected. Even if the impairment is one-off, it highlights the need for disciplined product investment and effective capital allocation.

Execution Risk In New Product ExpansionUnifoam offers a new route to growth, but its commercial contribution depends on successful trials, registration and regulatory approval. Delays or weaker adoption could postpone returns on development and launch spending, while adding execution complexity as Tristel expands beyond established products.

Tristel News

Tristel downgraded to Hold from Buy at Panmure Liberum

Panmure Liberum downgraded Tristel (TSNLF) to Hold from Buy with a 420 GBp price target Published first on...

4d ago

Tristel plc Rides Record Revenue and Margin Gains

Tristel plc (($GB:TSTL)) has held its Q4 earnings call. Read on for the main highlights of the call....

3d ago

Tristel lifts profits and dividend as U.S. growth and digital push gather pace

Tristel ( ($GB:TSTL) ) has shared an update. Hospital disinfectant manufacturer Tristel reported another year of double-digit growth,...

4d ago

Tristel Sets October Date for 2026 Results and Investor Briefings

Tristel ( ($GB:TSTL) ) just unveiled an announcement. Tristel plc, the AIM-listed infection prevention specialist, will publish its...

23d ago

Tristel Updates Share Capital After Employee Option Exercise

Tristel ( ($GB:TSTL) ) has shared an announcement. Tristel plc has issued and allotted 51,000 new ordinary shares...

2M ago

Tristel Issues New Shares After Employee Option Exercise, Lifts Voting Rights Total

Tristel ( ($GB:TSTL) ) has shared an announcement. Tristel plc, the AIM-listed infection prevention specialist using proprietary chlorine...

3M ago

Tristel launches premium paid tier of 3T compliance platform

The latest announcement is out from Tristel ( ($GB:TSTL) ). Tristel plc, a specialist in infection prevention solutions...

3M ago

Tristel posts double‑digit growth and boosts cash ahead of new CEO arrival

An update from Tristel ( ($GB:TSTL) ) is now available. Tristel has reported another year of strong trading,...

3M ago

Tristel deepens U.S. infection prevention footprint with APIC showcase and new digital offering

Tristel ( ($GB:TSTL) ) has provided an update. Tristel plc highlighted growing clinical engagement in the U.S. after...

4M ago

Tristel Names Medical Technology Veteran Chris Lee as New CEO to Drive Global Growth

Tristel ( ($GB:TSTL) ) has shared an update. Tristel, a specialist in infection prevention products for medical devices...

4M ago

R1V FAQ

What was Tristel PLC’s price range in the past 12 months?

Tristel PLC lowest stock price was €3.94 and its highest was €5.50 in the past 12 months.

What is Tristel PLC’s market cap?

Tristel PLC’s market cap is €228.63M.

When is Tristel PLC’s upcoming earnings report date?

Tristel PLC’s upcoming earnings report date is Feb 22, 2027 which is in 122 days.

How were Tristel PLC’s earnings last quarter?

Tristel PLC released its earnings results on Oct 19, 2026. The company reported €0.1 earnings per share for the quarter, missing the consensus estimate of €0.102 by -€0.001.

Is Tristel PLC overvalued?

According to Wall Street analysts Tristel PLC’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Tristel PLC pay dividends?

Tristel PLC does not currently pay dividends.

What is Tristel PLC’s EPS estimate?

Tristel PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Tristel PLC have?

Tristel PLC has 48,073,494 shares outstanding.

What happened to Tristel PLC’s price movement after its last earnings report?

Tristel PLC reported an EPS of €0.1 in its last earnings report, missing expectations of €0.102. Following the earnings report the stock price went down -6.139%.

Which hedge fund is a major shareholder of Tristel PLC?

Currently, no hedge funds are holding shares in DE:R1V

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Tristel Stock Smart Score

Neutral

Fundamentals

Return on Equity

23.05%

Trailing 12-Months

Asset Growth

6.47%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Tristel PLC

Tristel plc is a company specializing in the creation, production, and global distribution of products designed to prevent infections, serving both its home market in the UK and international clients. Its operations are structured around three core divisions: the decontamination of medical devices within hospital environments, the disinfection of hospital-based environmental surfaces, and an additional 'Other' category. The firm offers an extensive range of disinfection solutions for medical instruments under its Tristel brand. These solutions are applied across a wide spectrum of clinical areas, including airway management, cardiology, ear, nose and throat (ENT), endoscopy, gastrointestinal physiology, laboratory applications, ophthalmology, phlebotomy, reproductive health/IVF, general surface disinfection, ultrasound, urology, and women's health, alongside other specialized products. Tristel plc was established in 1993 and has its main office situated in Snailwell, United Kingdom.

Tristel (R1V) Earnings & Revenues

Historic Earnings Reports

R1V Stock 12 Month Forecast

Average Price Target

€4.99

▲(3.43% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"€2","5":"€5","2.75":"€2.75","3.5":"€3.5","4.25":"€4.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4.985148,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€4.99</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.985148,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€4.99</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.985148,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€4.99</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,2.75,3.5,4.25,5],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.7,4.721934461538462,4.743868923076923,4.765803384615385,4.7877378461538465,4.809672307692308,4.83160676923077,4.85354123076923,4.875475692307692,4.897410153846153,4.919344615384615,4.9412790769230766,4.963213538461538,{"y":4.985148,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.7,4.721934461538462,4.743868923076923,4.765803384615385,4.7877378461538465,4.809672307692308,4.83160676923077,4.85354123076923,4.875475692307692,4.897410153846153,4.919344615384615,4.9412790769230766,4.963213538461538,{"y":4.985148,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.7,4.721934461538462,4.743868923076923,4.765803384615385,4.7877378461538465,4.809672307692308,4.83160676923077,4.85354123076923,4.875475692307692,4.897410153846153,4.919344615384615,4.9412790769230766,4.963213538461538,{"y":4.985148,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.921,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.959,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.999,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.491,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.629,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.393,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.16,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.44,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.32,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.56,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.62,"date":1785542400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.779,"date":1788220800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.7,"date":1790812800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >